Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Rethinking osteoporosis drugs : can we simultaneously address sarcopenia?
Authors:ID Gavrilov, Zoran (Author)
ID Lojk, Jasna (Author)
Files:.pdf PDF - Presentation file, download (1,50 MB)
MD5: 73DA1C50B77146960122FC60B4CBEE2A
 
URL URL - Source URL, visit https://www.mdpi.com/1422-0067/26/14/6924
 
Language:English
Typology:1.02 - Review Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Osteoporosis and sarcopenia are two aspects of the geriatric syndrome that frequently occur together and affect one another in a condition referred to as osteosarcopenia. Preventive and treatment options for osteosarcopenia exist but are mainly focused on the treatment of osteoporosis, as there is still no FDA-approved treatment for sarcopenia. Drugs for osteoporosis include antiresorptive and anabolic drugs and hormonal replacement therapies and are prescribed based on age, BMD and other patient characteristics, which, however, do not include the possible co-existence of sarcopenia. As several studies and clinical trials have shown that the pharmacological treatment of osteoporosis can also affect muscle tissue, in either a positive or negative manner, sarcopenia should be another factor affecting the choice of treatment, especially when facing equal treatment options for osteoporosis. The aim of this review was to summarize our current knowledge on the effects of FDA-approved drugs for the treatment of osteoporosis on muscle quality, mass and function. A better understanding of the effects that certain drugs have on muscle tissue might in the future help us to simultaneously at least partially also address the wasting of muscle tissue and avoid further pharmacologically induced decline.
Keywords:osteoporosis, sarcopenia, osteosarcopenia, pharmacological treatment
Publication status:Published
Publication version:Version of Record
Year of publishing:2025
Number of pages:str. 1-38
Numbering:Vol. 26, iss. 14
PID:20.500.12556/DiRROS-24639 New window
UDC:61
ISSN on article:1422-0067
DOI:10.3390/ijms26146924 New window
COBISS.SI-ID:254168579 New window
Note:Nasl. z nasl. zaslona; Opis vira 21. 6. 2021;
Publication date in DiRROS:09.12.2025
Views:92
Downloads:40
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0298-2019
Name:Geni, hormonske in osebnostne spremembe pri metabolnih motnjah

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4527-2022
Name:Mišični sekretom in kostne celice - sodelovanje pri osteosarkopeniji (MiKOSA)

Funder:Other - Other funder or multiple funders
Funding programme:Univerzitetni klinični center Ljubljana
Project number:20230079
Name:Uvedba tehnologij LC-MS za podporo personalizirani terapiji (PerTeri-MS)

Funder:Other - Other funder or multiple funders
Funding programme:Univerzitetni klinični center Ljubljana
Project number:20250236
Name:Vpeljava in validacija metode za določanje antibiotikov na tehnologiji LC-MS/MS

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back